| Literature DB >> 31300605 |
Jamie Willows1, Katrina Wood2, Helen Bourne3, John Andrew Sayer1,4.
Abstract
Acquired C1-inhibitor (C1-INH) deficiency is a rare and potentially life-threatening disorder, which presents with recurrent attacks of non-pitting oedema to the face, airway, limbs or gastrointestinal tract. It is often associated with underlying B-cell lymphoproliferative disorders. We describe a case of a 73-year-old man with acquired C1-INH deficiency who presented with nephrotic syndrome due to glomerular IgM deposition, secondary to an underlying secretory lymphoplasmacytic lymphoma. Both the acquired C1-INH deficiency and the nephrotic syndrome resolved when the underlying B-cell lymphoma was treated with rituximab and bendamustine, suggesting the underlying lymphoproliferative malignancy was driving both disorders. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: haematology (incl blood transfusion); immunology; renal system
Mesh:
Substances:
Year: 2019 PMID: 31300605 PMCID: PMC6626461 DOI: 10.1136/bcr-2019-230388
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X